{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:23:47Z","timestamp":1780410227255,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jnma.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:42:33Z","timestamp":1771573353000},"page":"442-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary Enteric-type adenocarcinoma of the bladder managed with colon-type chemotherapy: A rare case and literature review"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6668-1829","authenticated-orcid":false,"given":"Jhonsley","family":"Frederic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Oladoyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9567-7756","authenticated-orcid":false,"given":"Jagannathan","family":"Geetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7089-4345","authenticated-orcid":false,"given":"Ayanna","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2377-1922","authenticated-orcid":false,"given":"Ralph","family":"Wehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayomide","family":"Sowemimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Lakshmi","family":"Kollepara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.jnma.2026.02.004_bib0001","first-page":"E20","article-title":"Treating bladder adenocarcinoma: current evidence and future perspectives","volume":"10","author":"Erlich","year":"2016","journal-title":"Can Urol Assoc J"},{"issue":"3","key":"10.1016\/j.jnma.2026.02.004_bib0002","first-page":"116","article-title":"Histologic variants of urothelial bladder cancer and nonurothelial histologies of bladder cancer: pathologic and clinical implications and treatment strategies","volume":"27","author":"Chalasani","year":"2009","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.jnma.2026.02.004_bib0003","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/modpathol.2014.158","article-title":"Update for the practicing pathologist: the international consultation on urologic disease-European association of urology international consultation on bladder Cancer","volume":"28","author":"Amin","year":"2015","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.jnma.2026.02.004_bib0004","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.jnma.2026.02.004_bib0005","first-page":"123","article-title":"Long-term outcomes after selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience","volume":"152","author":"Efstathiou","year":"2021","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.jnma.2026.02.004_bib0006","first-page":"866","article-title":"Trimodality therapy for muscle-invasive bladder cancer: results of RTOG 9906","volume":"31","author":"Mitin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnma.2026.02.004_bib0007","first-page":"45","article-title":"Enteric-type adenocarcinoma of the bladder: clinicopathological characteristics and outcomes","volume":"3","author":"Nakamura","year":"2023","journal-title":"AME Surg J"},{"key":"10.1016\/j.jnma.2026.02.004_bib0008","first-page":"50","article-title":"Molecular characterization of primary bladder adenocarcinoma and comparison with colorectal cancer","volume":"238","author":"Zhang","year":"2019","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jnma.2026.02.004_bib0009","article-title":"A comprehensive overview of molecular targets and immunotherapies in bladder cancer","volume":"12","author":"Khurana","year":"2022","journal-title":"Front Oncol"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968426000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968426000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:45:17Z","timestamp":1780407917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968426000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0027968426000283"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2026.02.004","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Enteric-type adenocarcinoma of the bladder managed with colon-type chemotherapy: A rare case and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Medical Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}